Summary

The global Calprotectin ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Calprotectin ELISA Kits leading manufacturers including Medix Biochemica, LifeSpan BioSciences, Inc, RayBiotech, Inc, Eagle Bioscience, Inc, Abbexa Ltd, Svar Life Science, Epitope Diagnostics, Inc, UHLMANN Diagnostics Corp, Biomatik, Creative Diagnostics, etc., dominate supply; the top five capture approximately % of global revenue, with Medix Biochemica leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Calprotectin ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medix Biochemica
LifeSpan BioSciences, Inc
RayBiotech, Inc
Eagle Bioscience, Inc
Abbexa Ltd
Svar Life Science
Epitope Diagnostics, Inc
UHLMANN Diagnostics Corp
Biomatik
Creative Diagnostics
Biorbyt
Segment by Type
Human Calprotectin ELISA Kits
Mouse/Rat Calprotectin ELISA Kits
Others
Segment by Application
Hospitals
Research Laboratories
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Calprotectin ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Calprotectin ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Calprotectin ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Human Calprotectin ELISA Kits
1.2.3 Mouse/Rat Calprotectin ELISA Kits
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Calprotectin ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Calprotectin ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Calprotectin ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Calprotectin ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Calprotectin ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Calprotectin ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Calprotectin ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Human Calprotectin ELISA Kits Market Size by Manufacturers
3.5.2 Mouse/Rat Calprotectin ELISA Kits Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Calprotectin ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Calprotectin ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Calprotectin ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Calprotectin ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Calprotectin ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Calprotectin ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America Calprotectin ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Calprotectin ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Calprotectin ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Calprotectin ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Calprotectin ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Calprotectin ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Calprotectin ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Calprotectin ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Calprotectin ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Calprotectin ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Calprotectin ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Calprotectin ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Calprotectin ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Calprotectin ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medix Biochemica
11.1.1 Medix Biochemica Corporation Information
11.1.2 Medix Biochemica Business Overview
11.1.3 Medix Biochemica Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.1.4 Medix Biochemica Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medix Biochemica Calprotectin ELISA Kits Sales by Product in 2024
11.1.6 Medix Biochemica Calprotectin ELISA Kits Sales by Application in 2024
11.1.7 Medix Biochemica Calprotectin ELISA Kits Sales by Geographic Area in 2024
11.1.8 Medix Biochemica Calprotectin ELISA Kits SWOT Analysis
11.1.9 Medix Biochemica Recent Developments
11.2 LifeSpan BioSciences, Inc
11.2.1 LifeSpan BioSciences, Inc Corporation Information
11.2.2 LifeSpan BioSciences, Inc Business Overview
11.2.3 LifeSpan BioSciences, Inc Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.2.4 LifeSpan BioSciences, Inc Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 LifeSpan BioSciences, Inc Calprotectin ELISA Kits Sales by Product in 2024
11.2.6 LifeSpan BioSciences, Inc Calprotectin ELISA Kits Sales by Application in 2024
11.2.7 LifeSpan BioSciences, Inc Calprotectin ELISA Kits Sales by Geographic Area in 2024
11.2.8 LifeSpan BioSciences, Inc Calprotectin ELISA Kits SWOT Analysis
11.2.9 LifeSpan BioSciences, Inc Recent Developments
11.3 RayBiotech, Inc
11.3.1 RayBiotech, Inc Corporation Information
11.3.2 RayBiotech, Inc Business Overview
11.3.3 RayBiotech, Inc Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.3.4 RayBiotech, Inc Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 RayBiotech, Inc Calprotectin ELISA Kits Sales by Product in 2024
11.3.6 RayBiotech, Inc Calprotectin ELISA Kits Sales by Application in 2024
11.3.7 RayBiotech, Inc Calprotectin ELISA Kits Sales by Geographic Area in 2024
11.3.8 RayBiotech, Inc Calprotectin ELISA Kits SWOT Analysis
11.3.9 RayBiotech, Inc Recent Developments
11.4 Eagle Bioscience, Inc
11.4.1 Eagle Bioscience, Inc Corporation Information
11.4.2 Eagle Bioscience, Inc Business Overview
11.4.3 Eagle Bioscience, Inc Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.4.4 Eagle Bioscience, Inc Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Eagle Bioscience, Inc Calprotectin ELISA Kits Sales by Product in 2024
11.4.6 Eagle Bioscience, Inc Calprotectin ELISA Kits Sales by Application in 2024
11.4.7 Eagle Bioscience, Inc Calprotectin ELISA Kits Sales by Geographic Area in 2024
11.4.8 Eagle Bioscience, Inc Calprotectin ELISA Kits SWOT Analysis
11.4.9 Eagle Bioscience, Inc Recent Developments
11.5 Abbexa Ltd
11.5.1 Abbexa Ltd Corporation Information
11.5.2 Abbexa Ltd Business Overview
11.5.3 Abbexa Ltd Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.5.4 Abbexa Ltd Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Abbexa Ltd Calprotectin ELISA Kits Sales by Product in 2024
11.5.6 Abbexa Ltd Calprotectin ELISA Kits Sales by Application in 2024
11.5.7 Abbexa Ltd Calprotectin ELISA Kits Sales by Geographic Area in 2024
11.5.8 Abbexa Ltd Calprotectin ELISA Kits SWOT Analysis
11.5.9 Abbexa Ltd Recent Developments
11.6 Svar Life Science
11.6.1 Svar Life Science Corporation Information
11.6.2 Svar Life Science Business Overview
11.6.3 Svar Life Science Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.6.4 Svar Life Science Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Svar Life Science Recent Developments
11.7 Epitope Diagnostics, Inc
11.7.1 Epitope Diagnostics, Inc Corporation Information
11.7.2 Epitope Diagnostics, Inc Business Overview
11.7.3 Epitope Diagnostics, Inc Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.7.4 Epitope Diagnostics, Inc Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Epitope Diagnostics, Inc Recent Developments
11.8 UHLMANN Diagnostics Corp
11.8.1 UHLMANN Diagnostics Corp Corporation Information
11.8.2 UHLMANN Diagnostics Corp Business Overview
11.8.3 UHLMANN Diagnostics Corp Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.8.4 UHLMANN Diagnostics Corp Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 UHLMANN Diagnostics Corp Recent Developments
11.9 Biomatik
11.9.1 Biomatik Corporation Information
11.9.2 Biomatik Business Overview
11.9.3 Biomatik Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.9.4 Biomatik Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Biomatik Recent Developments
11.10 Creative Diagnostics
11.10.1 Creative Diagnostics Corporation Information
11.10.2 Creative Diagnostics Business Overview
11.10.3 Creative Diagnostics Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.10.4 Creative Diagnostics Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Creative Diagnostics Recent Developments
11.11 Biorbyt
11.11.1 Biorbyt Corporation Information
11.11.2 Biorbyt Business Overview
11.11.3 Biorbyt Calprotectin ELISA Kits Product Models, Descriptions and Specifications
11.11.4 Biorbyt Calprotectin ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Biorbyt Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Calprotectin ELISA Kits Industry Chain
12.2 Calprotectin ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Calprotectin ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Calprotectin ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Calprotectin ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Calprotectin ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details